Lowering Blood Pressure Curing the Kidneys ~

Lowering Blood Pressure Curing the Kidneys ~

Nephrospec™

Transforming Kidney & Hypertension Care

Nephrospec™ is a revolutionary, non-invasive Electro-Hydraulic Acoustic Therapy (eHAT) device designed to treat chronic kidney disease (CKD) and hypertension safely and effectively. 

Advantages of Nephrospec™

Redefining Kidney Care

Life Changing. Non-Invasive. Innovative

Delays onset

of dialysis

Non-invasive

Painless

Safe

Efficient

6 treatments

3 weeks

Decreases blood pressure

Improves kidney function

Saves >80% of dialysis expenditure

Nephrospec™

Our patented eHAT technology is designed to:  

Stimulate the formation of new blood vessels enhancing microvascular function and reducing high blood pressure.

Revitalize kidney health by restoring damaged tissue and delaying or even preventing the need for dialysis.  

Enhance patients’ quality of life delivering measurable results within weeks. 

Reduces healthcare costs by up to 80%, making treatment both accessible and efficient.  

CLINICAL APPLICATIONS

  • Low–Energy Shockwave Therapy Improves Ischemic Kidney Microcirculation

    Zhang X, Krier JD, Carrascal CA, et al.

    J Am Soc Nephrol. 2016; 27(12):3715-3724. 

  • Low-Energy Shockwave Treatment Promotes Endothelial Progenitor Cell Homing to the Stenotic Pig Kidney

    Zhao Y, Santelli A, Zhu XY, et al.

    Cell Transplant. 2020; 29.

  • It Comes As a Shock Kidney Repair Using Shockwave Therapy

    Klomjit N, Lerman A, Lerman LO.

    Hypertension. Published online 2020:1696-1703. 

  • New List ItemMagnetic resonance elastography can monitor changes in medullary stiffness in response to treatment in the swine ischemic kidney

    Zhang X, Zhu X, Ferguson CM, et al.

    Magn Reson Mater Physics, Biol Med. 2018; 31(3):375-382.

  • Adjunctive mesenchymal stem / stromal cells augment microvascular function in poststenotic kidneys treated with low-energy shockwave therapy

    Description goes hereChen X-J, Zhang X, Jiang K, et al

    J Cell Physiol. 2020; 235(12):9806-9818. 

  • Innovation in Cardiovascular Interventions Meeting:

    First results using a new renal restoration approach to treat hypertension and preserve renal function in CKD patients - Presented by Prof. Talya Wolak